Renin-Angiotensin-System (RAS) und COVID-19 – Zur Verordnung von RAS-Blockern

Documenti analoghi

• The relentless crumbling of the renin-angiotensin system (RAS)-blockade halo
  di: Messerli, Franz H., et al.
  Pubblicazione: (2016)
• Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19: European Society of Hypertension COVID-19 Task Force Review of Evidence
  di: Kreutz, Reinhold, et al.
  Pubblicazione: (2020)
• Emergence and evolution of the renin–angiotensin–aldosterone system
  di: Fournier, David, et al.
  Pubblicazione: (2012)
• Prediction of the dose range for adverse neurological effects of amiodarone in patients from an in vitro toxicity test by in vitro–in vivo extrapolation
  di: Algharably, Engi Abd el-Hady, et al.
  Pubblicazione: (2021)
• COVID-19 and Renin Angiotensin Blockers: Current Evidence and Recommendations
  di: Messerli, Franz H., et al.
  Pubblicazione: (2020)